We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMD
501
DELISTED
Cantel Medical Corporation
CMD
| $4.94M | 0.01% |
44,344
-792
| -2% | -$88.8K |
|
|
EEX
502
DELISTED
Emerald Holding
EEX
| $4.88M | 0.01% |
250,588
-18,171
| -7% | -$378K |
|
503
Universal Health Services
UHS
$10.5B
| $4.83M | 0.01% |
40,796
-11,073
| -21% | -$1.32M |
|
|
BIG
504
DELISTED
Big Lots, Inc.
BIG
| $4.79M | 0.01% |
109,976
+109,828
| +74,208% | +$6.02M |
|
|
KNL
505
DELISTED
Knoll, Inc.
KNL
| $4.51M | 0.01% |
223,370
+2,411
| +1% | +$53.3K |
|
506
American Electric Power
AEP
$68.4B
| $4.48M | 0.01% |
65,358
+18,174
| +39% | +$1.22M |
|
|
HMHC
507
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $4.45M | 0.01% |
639,921
-298,787
| -32% | -$2.36M |
|
508
Truist Financial
TFC
$64B
| $4.41M | 0.01% |
84,640
-28,219
| -25% | -$1.52M |
|
509
iShares MSCI EAFE ETF
EFA
$80.2B
| $4.33M | 0.01% |
62,197
| – | – |
|
510
SLM Corp
SLM
$5.15B
| $4.25M | 0.01% |
379,500
-6,781
| -2% | -$76.1K |
|
511
State Street Blackstone Senior Loan ETF
SRLN
$5.36B
| $4.12M | 0.01% |
86,860
| – | – |
|
512
Genesco
GCO
$422M
| $4.03M | 0.01% |
99,246
+988
| +1% | +$36.7K |
|
|
PE
513
DELISTED
PARSLEY ENERGY INC
PE
| $2.93M | 0.01% |
100,979
-761,831
| -88% | -$20.3M |
|
514
KKR & Co
KKR
$92.3B
| $2.63M | 0.01% |
129,811
+7,691
| +6% | +$171K |
|
|
KE
515
Kimball Electronics
KE
$628M
| $2.6M | 0.01% |
160,747
+2,353
| +1% | +$42.3K |
|
|
CBB.PRB
516
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
| $2.58M | 0.01% |
15,219
| – | – |
|
517
Chubb
CB
$135B
| $2.53M | 0.01% |
18,507
-8,424
| -31% | -$1.22M |
|
518
Canadian Natural Resources
CNQ
$93.8B
| $2.42M | 0.01% |
157,105
+7,085
| +5% | +$114K |
|
519
Omnicom Group
OMC
$23.4B
| $2.26M | ﹤0.01% |
31,063
-741
| -2% | -$55.6K |
|
520
Kinder Morgan
KMI
$68.7B
| $2.07M | ﹤0.01% |
137,446
| – | – |
|
521
General Motors
GM
$76.8B
| $2.07M | ﹤0.01% |
56,943
-7,378
| -11% | -$299K |
|
522
AT&T
T
$163B
| $2.06M | ﹤0.01% |
76,429
-83,432
| -52% | -$2.32M |
|
|
SPTN
523
DELISTED
SpartanNash
SPTN
| $1.94M | ﹤0.01% |
112,804
-287,955
| -72% | -$6.17M |
|
|
EFT
524
Eaton Vance Floating-Rate Income Trust
EFT
$288M
| $1.6M | ﹤0.01% |
107,025
| – | – |
|
525
Valero Energy
VLO
$85.9B
| $1.57M | ﹤0.01% |
16,975
+541
| +3% | +$50.5K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.